These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 10510144)
1. Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man. Newby DE; Sciberras DG; Ferro CJ; Gertz BJ; Sommerville D; Majumdar A; Lowry RC; Webb DJ Br J Clin Pharmacol; 1999 Sep; 48(3):336-44. PubMed ID: 10510144 [TBL] [Abstract][Full Text] [Related]
2. Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability. Newby DE; Sciberras DG; Mendel CM; Gertz BJ; Boon NA; Webb DJ Br J Clin Pharmacol; 1997 May; 43(5):493-9. PubMed ID: 9159564 [TBL] [Abstract][Full Text] [Related]
3. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Witherow FN; Helmy A; Webb DJ; Fox KA; Newby DE Circulation; 2001 Oct; 104(18):2177-81. PubMed ID: 11684627 [TBL] [Abstract][Full Text] [Related]
4. Neurokinin-1 receptor desensitization to consecutive microdialysis infusions of substance P in human skin. Wong BJ; Tublitz NJ; Minson CT J Physiol; 2005 Nov; 568(Pt 3):1047-56. PubMed ID: 16123103 [TBL] [Abstract][Full Text] [Related]
5. Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans. Wong BJ; Minson CT J Physiol; 2006 Dec; 577(Pt 3):1043-51. PubMed ID: 17023511 [TBL] [Abstract][Full Text] [Related]
6. Kinetics and dynamics of the peripheral neurokinin-1 receptor antagonist SLV317 in healthy individuals. Hesse C; Luntz SP; Siedler H; Unnebrink K; Mikus G; de Bruijn M; Zondag E; de Vries M; Seibert-Grafe M; Haefeli WE Br J Clin Pharmacol; 2006 Apr; 61(4):414-9. PubMed ID: 16542202 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure. Stirrat CG; Venkatasubramanian S; Pawade T; Mitchell AJ; Shah AS; Lang NN; Newby DE Br J Clin Pharmacol; 2016 Oct; 82(4):974-82. PubMed ID: 27275843 [TBL] [Abstract][Full Text] [Related]
8. Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers. Walsh SL; Heilig M; Nuzzo PA; Henderson P; Lofwall MR Addict Biol; 2013 Mar; 18(2):332-43. PubMed ID: 22260216 [TBL] [Abstract][Full Text] [Related]
9. Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm. Cockcroft JR; Chowienczyk PJ; Brett SE; Ritter JM Br J Clin Pharmacol; 1994 Oct; 38(4):307-10. PubMed ID: 7530473 [TBL] [Abstract][Full Text] [Related]
10. Histamine-induced vasodilatation in the human forearm vasculature. Sandilands EA; Crowe J; Cuthbert H; Jenkins PJ; Johnston NR; Eddleston M; Bateman DN; Webb DJ Br J Clin Pharmacol; 2013 Nov; 76(5):699-707. PubMed ID: 23488545 [TBL] [Abstract][Full Text] [Related]
11. Opioid-like effects of the neurokinin 1 antagonist aprepitant in patients maintained on and briefly withdrawn from methadone. Jones JD; Speer T; Comer SD; Ross S; Rotrosen J; Reid MS Am J Drug Alcohol Abuse; 2013 Mar; 39(2):86-91. PubMed ID: 23421568 [TBL] [Abstract][Full Text] [Related]
12. Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo. Hall JM; Brain SD Br J Pharmacol; 1994 Oct; 113(2):522-6. PubMed ID: 7530573 [TBL] [Abstract][Full Text] [Related]
13. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant. Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387 [TBL] [Abstract][Full Text] [Related]
14. Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans. Witherow FN; Dawson P; Ludlam CA; Webb DJ; Fox KA; Newby DE Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1667-70. PubMed ID: 12869356 [TBL] [Abstract][Full Text] [Related]
15. Characterization of tachykinin receptors mediating plasma extravasation and vasodilatation in normal and acutely inflamed knee joints of the rat. Lam FY; Wong MC Br J Pharmacol; 1996 Aug; 118(8):2107-14. PubMed ID: 8864549 [TBL] [Abstract][Full Text] [Related]
16. Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man. Pellegrini MP; Newby DE; Maxwell S; Webb DJ Cardiovasc Res; 2001 Nov; 52(2):321-7. PubMed ID: 11684081 [TBL] [Abstract][Full Text] [Related]
17. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120 [TBL] [Abstract][Full Text] [Related]